296 related articles for article (PubMed ID: 21486184)
1. A novel solubility-modulated granules through porosity osmotic pump for controlled carvedilol delivery.
Song QL; Li P; Li YM
Pharm Dev Technol; 2012; 17(6):666-76. PubMed ID: 21486184
[TBL] [Abstract][Full Text] [Related]
2. Development of an osmotic pump system for controlled delivery of diclofenac sodium.
Emara LH; Taha NF; Badr RM; Mursi NM
Drug Discov Ther; 2012 Oct; 6(5):269-77. PubMed ID: 23229148
[TBL] [Abstract][Full Text] [Related]
3. Controlled delivery of carvedilol nanosuspension from osmotic pump capsule: in vitro and in vivo evaluation.
Liu D; Yu S; Zhu Z; Lyu C; Bai C; Ge H; Yang X; Pan W
Int J Pharm; 2014 Nov; 475(1-2):496-503. PubMed ID: 25219321
[TBL] [Abstract][Full Text] [Related]
4. Design and evaluation of osmotic pump-based controlled release system of Ambroxol Hydrochloride.
Cheng X; Sun M; Gao Y; Cao F; Zhai G
Pharm Dev Technol; 2011 Aug; 16(4):392-9. PubMed ID: 20429827
[TBL] [Abstract][Full Text] [Related]
5. Controlled porosity osmotic pump-based controlled release systems of pseudoephedrine. I. Cellulose acetate as a semipermeable membrane.
Makhija SN; Vavia PR
J Control Release; 2003 Apr; 89(1):5-18. PubMed ID: 12695059
[TBL] [Abstract][Full Text] [Related]
6. Chitosan-based controlled porosity osmotic pump for colon-specific delivery system: screening of formulation variables and in vitro investigation.
Liu H; Yang XG; Nie SF; Wei LL; Zhou LL; Liu H; Tang R; Pan WS
Int J Pharm; 2007 Mar; 332(1-2):115-24. PubMed ID: 17052871
[TBL] [Abstract][Full Text] [Related]
7. Solubility-modulated monolithic osmotic pump tablet for atenolol delivery.
Liu L; Wang X
Eur J Pharm Biopharm; 2008 Feb; 68(2):298-302. PubMed ID: 17560099
[TBL] [Abstract][Full Text] [Related]
8. [The delivery mechanism of micro-porous osmotic pump tablets].
Zhao XL; Li Q; Gong XF; Li SM
Yao Xue Xue Bao; 2007 Feb; 42(2):226-30. PubMed ID: 17518057
[TBL] [Abstract][Full Text] [Related]
9. A novel controlled porosity osmotic pump system for sodium ferulate.
He L; Gong T; Zhao D; Zhang ZR; Li L
Pharmazie; 2006 Dec; 61(12):1022-7. PubMed ID: 17283661
[TBL] [Abstract][Full Text] [Related]
10. Development and Evaluation of a Once-Daily Controlled Porosity Osmotic Pump of Tapentadol Hydrochloride.
Thakkar HP; Pancholi N; Patel CV
AAPS PharmSciTech; 2016 Oct; 17(5):1248-60. PubMed ID: 26677859
[TBL] [Abstract][Full Text] [Related]
11. Osmotic pellet system comprising osmotic core and in-process amorphized drug in polymer-surfactant layer for controlled delivery of poorly water-soluble drug.
Saindane N; Vavia P
J Pharm Sci; 2012 Sep; 101(9):3169-79. PubMed ID: 22418998
[TBL] [Abstract][Full Text] [Related]
12. Preparation of a push-pull osmotic pump of felodipine solubilized by mesoporous silica nanoparticles with a core-shell structure.
Wu C; Zhao Z; Zhao Y; Hao Y; Liu Y; Liu C
Int J Pharm; 2014 Nov; 475(1-2):298-305. PubMed ID: 25148731
[TBL] [Abstract][Full Text] [Related]
13. Experiment on formulation and drug release behavior of porosity asymmetric membrane capsules in vitro.
Fu HX; Li H; Zhang FZ; Zhao YZ; Wan CW; Chen MT; Jia XC; Yan L; Sun CC; Xu YY
Drug Dev Ind Pharm; 2012 Jun; 38(6):670-8. PubMed ID: 22469006
[TBL] [Abstract][Full Text] [Related]
14. Controlled porosity solubility modulated osmotic pump tablets of gliclazide.
Banerjee A; Verma PR; Gore S
AAPS PharmSciTech; 2015 Jun; 16(3):554-68. PubMed ID: 25378281
[TBL] [Abstract][Full Text] [Related]
15. Micro-porous surfaces in controlled drug delivery systems: design and evaluation of diltiazem hydrochloride controlled porosity osmotic pump using non-ionic surfactants as pore-former.
Adibkia K; Ghanbarzadeh S; Shokri MH; Arami Z; Arash Z; Shokri J
Pharm Dev Technol; 2014 Jun; 19(4):507-12. PubMed ID: 23763379
[TBL] [Abstract][Full Text] [Related]
16. Applicability of (SBE)7m-beta-CD in controlled-porosity osmotic pump tablets (OPTs).
Okimoto K; Tokunaga Y; Ibuki R; Irie T; Uekama K; Rajewski RA; Stella VJ
Int J Pharm; 2004 Nov; 286(1-2):81-8. PubMed ID: 15501004
[TBL] [Abstract][Full Text] [Related]
17. Design of a 24-hour controlled porosity osmotic pump system containing PVP: formulation variables.
Yakubu R; Peh KK; Tan YT
Drug Dev Ind Pharm; 2009 Dec; 35(12):1430-8. PubMed ID: 19929202
[TBL] [Abstract][Full Text] [Related]
18. Influence of excipients, drugs, and osmotic agent in the inner core on the time-controlled disintegration of compression-coated ethylcellulose tablets.
Lin SY; Lin KH; Li MJ
J Pharm Sci; 2002 Sep; 91(9):2040-6. PubMed ID: 12210050
[TBL] [Abstract][Full Text] [Related]
19. A controlled porosity osmotic pump system with biphasic release of theophylline.
Bi Y; Mao S; Gan L; Li Y; Wang C; Xu N; Zheng Y; Cheng Q; Hou S
Chem Pharm Bull (Tokyo); 2007 Nov; 55(11):1574-80. PubMed ID: 17978514
[TBL] [Abstract][Full Text] [Related]
20. A water-insoluble drug monolithic osmotic tablet system utilizing gum arabic as an osmotic, suspending and expanding agent.
Lu EX; Jiang ZQ; Zhang QZ; Jiang XG
J Control Release; 2003 Oct; 92(3):375-82. PubMed ID: 14568418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
